Auptim offers an AI‑driven workflow platform that converts informal notes, chat messages, and emails into structured tickets, prioritizes backlogs, and automates bulk task movements.
Funding
Funding not disclosed
Founders
Product
Problem
Teams handling supply chain, regulated biotech, and shift‑based operations often rely on spreadsheets, ad‑hoc notes, and manual admin to track work, leading to lost information, duplicated effort, and bottlenecks in handoffs.
Solution
Auptim delivers an AI‑driven workflow platform that turns informal notes into structured tickets, prioritizes backlogs, and automates bulk task movements. Its Vega Assistant parses chat and handwritten inputs, creates and updates issues, and links them to code in GitHub. Integrated AI agents (Claude Code, Codex) can pull board context, generate epics, and synchronize commits, reducing the need for dedicated administrators. The system also provides multilingual chat translation and a unified view of decisions, sprint plans, and repository activity, keeping real‑world operators focused on execution.
Target Audience
Primary users are small to midsize operational teams in supply chain, regulated biotech, and shift‑based workplaces, as well as software development teams that need tight integration between project boards and code repositories.
Features
- Vega Assistant that converts rough notes, chat messages, and emails into fully formed tickets with proper metadata
- Automatic backlog search, priority scoring, and bulk work‑item re‑assignment to streamline sprint planning
- Deep GitHub integration that reads code snippets, identifies problem locations, and drafts code‑aware tickets
- AI companion (Claude Code, Codex) that can create epics, link branches, and record session trails directly from the board
- Multilingual translation layer for chat, tickets, and comments to support distributed teams
- Dashboard that surfaces summarized decisions, sprint progress, and real‑time analytics for operators
- Low‑admin SaaS design tailored for small teams in supply chain, biotech, and shift‑based environments